The HZI is continuously building a network of closely aligned strategic partnerships with universities, research institutions and hospitals. Its primary objective is to create synergies which establish the optimal conditions for an efficient transfer of knowledge from basic research to medical application: HZI Locations.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
Systems BiologyThe goal of systems biology is to describe the dynamic processes of life and of biological systems using mathematical models. In line with the foundation of the new Braunschweig Integrated Centre of Systems Biology (BRICS) we have compiled some background information about systems biology for you: To the systems biology feature.
The 10th TWINCORE Symposium takes place on 30st / 31st August 2018. International Infection researchers talk about “Frontiers in translational research“.
Results 11 to 20 of total 327
New substances are showing antagonistic activity towards roundworms and germs
British professional magazine "The Medicine Maker" includes Claus-Michael Lehr in the top hundred most influential experts in drug development in 2018 again
Biotech pioneer moves antibody discovery platform and cooperates with the Helmholtz Centre for Infection Research
HIRI Scientist profile RNA to fingerprint individual cells
HZI researchers have uncovered how a cancer-causing virus specifically targets a protein of its host to successfully establish infection
Researchers from Braunschweig developed a universal method that allows them to proliferate cells of any donor tissue while maintaining their function
HIPS researchers developed a novel small molecule that suppresses the production of hazardous biofilms and is suitable for oral administration
HIRI researchers discover further applications for Cas9 scissors
HZI researchers detect a new crucial role for a known receptor molecule in the first defensive response of the immune system to influenza infection of the lung
HIPS scientist Anna Hirsch receives an ERC Starting Grant of €1.5 million in order to establish innovative methods for the identification of drug target structures